Spots Global Cancer Trial Database for Determination of Carboplatin's Optimal Plasmatic Exposure
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Determination of Carboplatin's Optimal Plasmatic Exposure
Official Title: Determination of Carboplatin's Optimal Plasmatic Exposure
Study ID: NCT00145028
Conditions
Interventions
Study Description
Brief Summary: To determine Carboplatin's optimal exposures(optimal AUCs)and parameters they depend on.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Paul Papin, Angers, , France
Institut Bergonié, Bordeaux, , France
Clinique Pasteur, Evreux, , France
CHU A. Michallon, Grenoble, , France
Centre Oscar Lambert, Lille, , France
CHU de la Timone, Marseille, , France
Centre Val d'Aurelle, Montpellier, , France
Centre Antoine Lacassagne, Nice, , France
CHU de Nîmes, Nîmes, , France
Hopital Européen Georges Pompidou, Paris, , France
Clinique Mathilde, Rouen, , France
Centre René Gauducheau, Saint Herblain (Nantes), , France
CHU de Toulouse Rangueil, Toulouse, , France
Institut Claudius Regaud, Toulouse, , France
CHRU Bretonneau, Tours, , France
Contact Details
Name: Laurence GLADIEFF, Doctor
Affiliation: Institut Claudius Regaud
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
